These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8339777)
21. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies. Liou HH; Chen RC; Tsai YF; Chen WP; Chang YC; Tsai MC Toxicol Appl Pharmacol; 1996 Mar; 137(1):34-41. PubMed ID: 8607139 [TBL] [Abstract][Full Text] [Related]
22. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease. Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M Neuroscience; 1995 Jun; 66(3):507-21. PubMed ID: 7644016 [TBL] [Abstract][Full Text] [Related]
23. Quinolinic acid neurotoxicity: in vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection. Santamaría A; Ríos C; Pérez P; Flores A; Galván-Arzate S; Osorio-Rico L; Solís F Toxicol Lett; 1996 Oct; 87(2-3):113-9. PubMed ID: 8914619 [TBL] [Abstract][Full Text] [Related]
24. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795 [TBL] [Abstract][Full Text] [Related]
25. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. Henze C; Earl C; Sautter J; Schmidt N; Themann C; Hartmann A; Oertel WH Brain Res; 2005 Aug; 1052(1):97-104. PubMed ID: 16005444 [TBL] [Abstract][Full Text] [Related]
26. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III). Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817 [TBL] [Abstract][Full Text] [Related]
27. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease. Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177 [TBL] [Abstract][Full Text] [Related]
28. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus. Sloot WN; van der Sluijs-Gelling AJ; Gramsbergen JB J Neurochem; 1994 Jan; 62(1):205-16. PubMed ID: 7505311 [TBL] [Abstract][Full Text] [Related]
29. Acute intrastriatal injection of quinolinic acid provokes long-lasting misregulation of the cytoskeleton in the striatum, cerebral cortex and hippocampus of young rats. Pierozan P; Gonçalves Fernandes C; Ferreira F; Pessoa-Pureur R Brain Res; 2014 Aug; 1577():1-10. PubMed ID: 24976581 [TBL] [Abstract][Full Text] [Related]
30. Remote microglial activation in the quinolinic acid model of Huntington's disease. Töpper R; Gehrmann J; Schwarz M; Block F; Noth J; Kreutzberg GW Exp Neurol; 1993 Oct; 123(2):271-83. PubMed ID: 8405289 [TBL] [Abstract][Full Text] [Related]
31. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Emgård M; Karlsson J; Hansson O; Brundin P Exp Neurol; 1999 Nov; 160(1):279-88. PubMed ID: 10630212 [TBL] [Abstract][Full Text] [Related]
32. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum. Guidetti P; Wu HQ; Schwarcz R Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450 [TBL] [Abstract][Full Text] [Related]
34. Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains. Robichon R; Jaafar A; Terqui M; Brachet P; Peschanski M Exp Neurol; 2005 Aug; 194(2):333-40. PubMed ID: 16022861 [TBL] [Abstract][Full Text] [Related]
35. The effect of quinolinic acid administered during pregnancy on the nigro-striatal complex of rat's offspring: ultrastructural investigation. Beskid M; Jachimowicz J; Taraszewska A Exp Toxicol Pathol; 1995 Dec; 47(6):479-84. PubMed ID: 8871087 [TBL] [Abstract][Full Text] [Related]
36. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat. Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136 [TBL] [Abstract][Full Text] [Related]
37. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain edema. Vizuete ML; Venero JL; Vargas C; Ilundáin AA; Echevarría M; Machado A; Cano J Neurobiol Dis; 1999 Aug; 6(4):245-58. PubMed ID: 10448052 [TBL] [Abstract][Full Text] [Related]
38. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats. Ceresoli-Borroni G; Guidetti P; Schwarcz R J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532 [TBL] [Abstract][Full Text] [Related]
39. In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage. Coyle JT; Molliver ME; Kuhar MJ J Comp Neurol; 1978 Jul; 180(2):301-23. PubMed ID: 659663 [TBL] [Abstract][Full Text] [Related]
40. Selective enhancement of tubulin gene expression and increase in oligo(dT)-bound RNA in the rat brain after nigrostriatal pathway unilateral lesion and treatment with ganglioside. Yavin E; Gil S; Consolazione A; dal Toso R; Leon A J Neurosci Res; 1987; 18(4):615-20. PubMed ID: 3437475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]